Preview Mode Links will not work in preview mode

Nov 30, 2022

Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:

  • PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00)
  • Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03)
  • Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09)
  • Tumor...


Nov 29, 2022

Featuring a slide presentation and related discussion from Dr Toni Choueiri, including the following topics:

  • Evolution in the management of renal cell carcinoma (RCC) (0:00)
  • Adjuvant therapy for intermediate- or high-risk RCC (1:52)
  • Front-line therapy for patients with metastatic RCC (8:39)
  • New agents for the treatment...


Nov 29, 2022

Featuring an interview with Dr Toni Choueiri, including the following topics:

  • Case: A woman in her early 70s with a large kidney tumor and multiple pulmonary nodules (0:00)
  • Case: A woman in her early 60s diagnosed with metastatic clear cell renal cell carcinoma (RCC) (12:52)
  • Approach to adjuvant treatment for RCC...


Nov 28, 2022

Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 2: Anti-PD-1 and PD-L1 Monotherapy for NSCLC — Dr Stephen Liu

CME information and select publications


Nov 28, 2022

Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 1: Current Treatment Landscape for Non-Small Cell Lung Cancer (NSCLC) — Dr John Heymach

CME information and select...